Rebalancing Healthcare Strategies Amid Rising Geopolitical Volatility in Mexico and Latin America

Join us in Mexico City at the JW Marriott Polanco!

In 2026, Mexico’s healthcare market is being shaped by a moderate economic recovery, USMCA renegotiations, shifting trade and regulatory dynamics, and a continued rebalancing between public and private care systems. As policy, procurement, and market access conditions evolve, healthcare executives must reassess demand assumptions, portfolio priorities, and go-to-market strategies across their industry sectors.

Mexico’s alignment with US trade priorities and its stance toward Chinese and Indian suppliers are reshaping competitive dynamics, while the early stages of the 2027–2028 consolidated tender are already underway—raising critical questions around execution, supply continuity, and payment risk. At the same time, changes in COFEPRIS leadership have renewed focus on the sustainability of recent gains in approval timelines and digitalization, with direct implications for market access planning.

Join us for an executive discussion to explore:

• The Latin American macroeconomic and healthcare context for 2026 and beyond
• The outlook for healthcare spending in 2026 amid budget constraints and a moderate economic recovery
• Where the 2027–2028 consolidated tender stands and how companies can build competitive advantage
• The impact of regulatory leadership changes on COFEPRIS approval timelines and digitalization
• Progress on healthcare initiatives and reforms reshaping planning and purchasing across the public sector
• The continued shift of patients from public care to low-cost private models driven by out-of-pocket spending
• Sustained opportunities in the high-cost segment supported by a resilient premium insurance market
• The growing influence of payers and insurers in shaping access, pricing, and demand in the private sector

This executive session will bring healthcare leaders together to reassess risks, identify selective growth opportunities, and define strategies to compete effectively across Mexico’s public and private healthcare markets in 2026.